According to CDC statistics, 23.6 million people in North America
(7.8% of the population) have DM. In 2007 it was made
diagnosis of 1.6 million new cases of diabetes in people
20 years or more, reaching a prevalence of DM1 in residents
United States between 0 and 19 years, from 1.7 / 1,000 population (27). incidence
DM1 overall has increased over the past decades to
5.3% annually in the U.S. If current trends continue, it is expected that
duplication of new cases in European children under 5
between 2005 and 2020, and the prevalence of cases in individuals under
15 years will increase by 70%, a phenomenon characteristic left shift toward a younger age, without being entirely elucidated the factors involved in the phenomenon of growth
pathology (27). The process seems to develop in patients genetically
susceptible triggered by one or more environmental agents, with
progression in months or years during which the patient is
euglycemic asymptomatic, reflecting the large number of B cells
must be destroyed in order to present the state of hyperglycemia